Medication info

Korean 20% Dextrose Injection

Prescription medicationInjectionsIntravenous injection
Ingredient · strength
Glucose›200g / 1000mL
Manufacturer / importer
Daehan Pharmaceutical Co., Ltd.
Appearance
This injectable solution is a colorless and transparent liquid contained in a colorless and transparent container made of glass or polypropylene, multilayer film plastic material.
Packaging
300mL bottle, 600mL bottle
Approval status
Active

MFDS item code 198600196 · Notified 1986.06.21 · Insurance code 645100151

Summary

Main use
Fluid and energy replacement (such as for hypoglycemia), and treatment of heart disease and drug or toxic substance poisoning
Who receives it
Adults
Adult administration
Adults: Administer 20∼500 mL intravenously per dose. The intravenous drip infusion rate should not exceed 0.5 g/kg of glucose per hour. Use an appropriate amount for dissolving or diluting injectable drugs. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
Daehan Pharmaceutical Co., Ltd.

Efficacy & effects

Fluid and energy replacement (such as for hypoglycemia), and treatment of heart disease and drug or toxic substance poisoning

  • Hyperkalemia
  • circulatory collapse
  • hypoglycemia
View approved original text

This medication is used to provide energy in cases of hyperkalemia, circulatory collapse, and hypoglycemia. It also helps to supply moisture and energy when treating heart disease in conjunction with G, I, K therapy. It is effectively used in cases of drug or poison intoxication. Therefore, it helps to improve electrolyte imbalance or energy deficiency in the blood.

How it is given

Adult administration

Adults: Administer 20∼500 mL intravenously per dose. The intravenous drip infusion rate should not exceed 0.5 g/kg of glucose per hour. Use an appropriate amount for dissolving or diluting injectable drugs. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication should be handled carefully, especially when used in children or the elderly, as glass shards may mix when opening the ampule. Caution is necessary when administering glucose-containing injections intravenously, as this may increase the consumption of vitamin B1 in the body, potentially leading to fatal deficiency. This medication should not be used in patients with certain conditions such as dehydrated hyperglycemia, excess fluid state, hyperglycemia, acidosis, hypokalemia, hyperosmolar coma, and glucose intolerance. Administering this medication in its hypertonic form may be dangerous for patients with spinal hemorrhage, intracranial hemorrhage, or severe dehydration. Patients with potassium, phosphorus, magnesium deficiencies, poor kidney function, heart failure, severely ill patients, and diabetics should use this medication with caution. Care should be taken to avoid electrolyte imbalance, dehydration, hyperosmolarity, and other side effects when administering in large amounts or at a rapid rate. Long-term use may affect insulin secretion; therefore, insulin should be administered as needed, and blood glucose and electrolyte levels should be checked frequently. During pregnancy, this medication should only be administered if the therapeutic benefits outweigh the risks to the fetus. Children and neonates have poor fluid and electrolyte regulation, so blood glucose and electrolyte status must be closely monitored during administration. Elderly patients may have reduced physical function, so this medication should be used more cautiously. Overdosage may lead to hyperglycemia or diabetic symptoms, necessitating appropriate treatment such as insulin administration. Subcutaneous injections should be avoided as they can cause local irritation and circulatory failure; use immediately after opening, and dispose of any remaining medication. To reduce the risk of infection during injections, cleanliness must be maintained, and potential interactions and adverse reactions should be thoroughly considered when mixing medications. Additionally, to avoid air embolism risks, continuous connection of containers should be avoided, and warming to body temperature is safe when storing in a refrigerator.

Side effects

  • Electrolyte loss
  • elevated bilirubin levels
  • elevated lactate levels
  • hypokalemia
  • hyperosmolar coma
  • acidosis
  • dehydration
  • hyperosmolarity
  • polyuria
  • fluid or solute overload
Show 11 more
  • fluid-electrolyte imbalance
  • congestion
  • pulmonary edema
  • hyperglycemia
  • renal loss
  • fever
  • phlebitis
  • thrombosis
  • blood loss
  • injection site pain
  • uremia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air, ideally at room temperature between 1 degree and 30 degrees Celsius. This storage method helps maintain the medication's effectiveness and prevents degradation.

Appearance and packaging

Appearance

This injectable solution is a colorless and transparent liquid contained in a colorless and transparent container made of glass or polypropylene, multilayer film plastic material.

Package unit

300mL bottle, 600mL bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.